← All ETFs

Invesco S&P 500 Equal Weight Health Care ETF

RSPHHoldings as of July 31, 2026 (filed Sep 28, 2026)Form N-PORT on SEC EDGAR ↗

14% in rough estimates

Value per share

$27.23

if its companies were priced at our values from their reports

Last close

$41.06

Nov 13, 2026

50.8% above its value value

52 of 63 holdings valued89% of the fund

If the companies in RSPH were priced at the values we work out from their own financial reports, one share would be worth about $27.23. It last closed at $41.06. Read the other way, that is the same gap: the value is 33.7% below the price.

What the fund holds

11% priced below value 78% priced above value11% not valued

14% of the fund is in companies with a rough estimate (marked ! below).

What moves the number

How RSPH gets from its last close of $41.06 to its value of $27.23. Each bar starts where the previous one ends. A company priced above its value pulls the number down; one priced below it pushes the number up. Holdings we do not value leave it where it is.

  1. Last close$41.06
  2. Centene Corp+$1.28
  3. Charles River Laboratories International, Inc.−$0.79
  4. Revvity, Inc.−$0.72
  5. Mettler Toledo International Inc/−$0.63
  6. Agilent Technologies, Inc.−$0.60
  7. All other holdings−$12.37
  8. Value per share$27.23

The steps add up to the $13.83 gap between the last close and the value.

Largest holdings

Showing 10 of 63 holdings.

CompanyShare of fundLast closeFair valueGapEffect
2.5%$301.68$154.22 95.6% above−$0.50
2.5%$338.01$74.83 351.7% above−$0.79
2.2%$955.65$527.63 81.1% above−$0.40
2.1%$1,740$462.21 276.3% above−$0.63
2.1%$154.54$24.27 536.9% above−$0.72
2.0%$218.05$138.46 57.5% above−$0.30
2.0%$265.03$112.81 134.9% above−$0.47
2.0%$700.18$187.16 274.1% above−$0.59
1.9%$1,104$721.84 52.9% above−$0.27
Bio-Techne CorpTECH Rough estimate
1.9%$72.79$17.75 310.1% above−$0.59
1.9%$168.04$97.44 72.5% above−$0.32
1.9%$370.64$231.75 59.9% above−$0.29
Amgen IncAMGN
1.9%$465.55$357.36 30.3% above−$0.18
1.8%$194.51$266.70 27.1% below+$0.28
1.8%$498.88$366.05 36.3% above−$0.20
1.8%$173.91$33.24 423.2% above−$0.60
Viatris IncVTRS
1.8%$20.84$13.57 53.6% above−$0.26
AbbVie Inc.ABBV
1.8%$295.00$138.09 113.6% above−$0.39
Biogen Inc.BIIB
1.8%$253.51$75.06 237.8% above−$0.51
1.8%$83.05$48.77 70.3% above−$0.30
1.8%$281.10$159.42 76.3% above−$0.31
1.7%$102.86$48.86 110.5% above−$0.38
Eli Lilly & CoLLY Rough estimate
1.7%$1,445$276.68 422.2% above−$0.58
1.7%$359.02$195.81 83.4% above−$0.32
1.7%$259.39$131.21 97.7% above−$0.35
1.7%$264.36$109.40 141.6% above−$0.42
1.7%$25.80$33.77 23.6% below+$0.22
Waters CorpWAT · Not valued: too few usable years of reports
1.7%$460.58–––
1.7%$704.46$184.66 281.5% above−$0.52
Danaher CorpDHR Rough estimate
1.7%$232.99$44.62 422.1% above−$0.57
1.7%$416.50$100.16 315.8% above−$0.53
1.7%$107.19$49.08 118.4% above−$0.38
1.7%$147.76$70.51 109.6% above−$0.36
1.7%$239.53$144.44 65.8% above−$0.27
Humana IncHUM Rough estimate
1.7%$450.47$785.38 42.6% below+$0.51
1.7%$538.54$246.11 118.8% above−$0.37
Abbott LaboratoriesABT Rough estimate
1.7%$108.51$40.83 165.8% above−$0.42
1.6%$285.96$99.76 186.7% above−$0.44
Moderna, Inc.MRNA · Not valued: too few usable years of reports
1.6%$223.22–––
1.6%$103.22$84.75 21.8% above−$0.12
Incyte CorpINCY · Not valued: too few usable years of reports
1.6%$120.96–––
1.6%$63.42$67.67 6.3% below+$0.04
Pfizer IncPFE · Not valued: too few usable years of reports
1.5%$28.90–––
Dexcom IncDXCM Rough estimate
1.5%$83.28$27.42 203.7% above−$0.42
Solventum CorpSOLV · Not valued: too few usable years of reports
1.5%$89.09–––
1.5%$86.23$45.39 90.0% above−$0.29
Centene CorpCNC Rough estimate
1.5%$71.28$221.02 67.7% below+$1.28
Intuitive Surgical IncISRG Rough estimate
1.5%$443.47$176.06 151.9% above−$0.36
Invesco Private Prime FundCash collateral for shares the fund lent out; it is owed back
1.5%––––
1.4%$429.63$609.12 29.5% below+$0.25
1.4%$83.82$62.83 33.4% above−$0.14
Insulet CorpPODD · Not valued: price far above what its reports support
1.4%$152.50–––
Cigna GroupCI · Not valued: too few usable years of reports
1.4%$297.01–––
1.4%$309.64$146.54 111.3% above−$0.29
1.4%$407.52$374.54 8.8% above−$0.05
1.3%$168.35$109.49 53.8% above−$0.19
1.3%$62.66$31.41 99.5% above−$0.26
Boston Scientific CorpBSX Rough estimate
1.2%$44.35$29.34 51.2% above−$0.17
1.2%$89.35$171.11 47.8% below+$0.47
1.2%$174.43$159.30 9.5% above−$0.04

Share of fund: how much of the fund is in the company. Gap: the company's last close compared with the value we work out from its reports. Effect: how much the company moves the value of one RSPH share. Rough estimate (!): our value is far from the market price, probably because the reports miss something, like fast growth. We still use it. Not valued: we do not put a number on the company; it counts at its market price, so it does not move the value.

How we got this number

  1. Look insideWe read the fund's latest holdings report to the SEC, for July 31, 2026. It lists 63 holdings.
  2. Value each companyFor each company we value, we use the value we work out from its own financial reports instead of its stock price. That covers 52 of the holdings, 89% of the fund.
  3. Add it back upEverything else (cash, bonds and companies we do not value) stays at its market price. Added back up and split per share, one RSPH share comes to $27.23.

Good to know

Technical details

The formula: value per share = last close × (1 + the sum over valued holdings of share of fund × (value ÷ last close − 1)). Each holding's share of the fund is measured against the fund's net assets at today's closes. Cash the fund holds as collateral for shares it has lent out is listed in its report but is owed back, so it does not count toward the fund's size.

Net assets, all share classes, Jul 31, 2026
$767M
Net assets at today's closes
$873M
Holdings in the report
63
Matched to a ticker
59
Valued
52
Short positions and derivatives
0.00% of net assets
Price against value
+50.8%
Value against last close
-33.7%
SEC series
S000060814
Filing (accession)
0001209466-26-001329

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the value per share above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Holdings: SEC Form N-PORT for the period ended July 31, 2026 (accession 0001209466-26-001329). Company values: this site's filings-based values (Nov 14, 2026). Closing prices: IEX Historical Data (Nov 13, 2026).